Daehan New Pharm Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of Daehan New Pharm
Key information
n/a
Debt to equity ratio
n/a
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | n/a |
| Total liabilities | n/a |
| Total assets | n/a |
Recent financial health updates
Recent updates
Daehan New Pharm Co., Ltd.'s (KOSDAQ:054670) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Mar 10
What Type Of Shareholders Own The Most Number of Daehan New Pharm Co., Ltd. (KOSDAQ:054670) Shares?
Feb 17Here's Why Daehan New Pharm (KOSDAQ:054670) Can Manage Its Debt Responsibly
Jan 21
If You Had Bought Daehan New Pharm's (KOSDAQ:054670) Shares Five Years Ago You Would Be Down 25%
Dec 31Is Daehan New Pharm Co., Ltd.'s(KOSDAQ:054670) Recent Stock Performance Tethered To Its Strong Fundamentals?
Dec 10In this section we usually analyse Daehan New Pharm's finance health to determine how well-positioned it is against times of financial distress, in particular, its ability to manage its cash and debt levels. Daehan New Pharm has not provided adequate balance sheet data, its financial health cannot be properly assessed as it.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have financial information.
Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if A054670's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if A054670's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate A054670's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if A054670's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if A054670's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if A054670's interest payments on its debt are well covered by EBIT.